McDonnell Boehnen Hulbert & Berghoff LLP is proud to be an official sponsor of the 2018 Tech Transfer Summit (“TTS”) Global Initiative. Founded in 2007, the TTS Global Initiative is the premier international platform bringing together critical opinions from all stakeholders groups involved in the early stage biotechnology healthcare sector. The TTS Global Initiative has one primary objective: to foster innovation by accelerating the translation of world-class life sciences and biomedical research from the lab to the patient and the market. The TTS Global Initiative revolves around one central principal; that the best way to foster innovation is to bring together decision-makers to debate and deliberate the challenges and engage in high-quality networking, deal making and business development.
The TTS Global Initiative is comprised of four key events including: TTS Australia, TTS North America, TTS Europe and TTS Latin America.
MBHB partners Dr. Kevin Noonan Dr. Paul Tully and Dr. Dmitriy Vinarov are set to attend these events on behalf of the firm.